Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Daratumumab plus VTd voor en na SCT bij nieuw gediagnosticeerd MM
aug 2019 | MM